Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Oral Fluid HIV Tests Give False-Positive Results

By Labmedica staff writers
Posted on 01 Jul 2008
There have been increases in the number of false-positive results for human immunodeficiency virus (HIV) in oral fluid testing in New York (NY, USA).

The Morbidity and Mortality Weekly Report (MMWR) of June 18, 2008, reviewed the increases in these false-positives, which were identified in New York City from the years 2005 to 2008, and the manner with which the officials there responded. More...
According to the report, the reason for the episodic increase in false-positive oral-fluid tests has not yet been determined. Currently, the New York City Department of Health and Mental Hygiene (NY, USA) suspended the use of oral fluid testing in its sexually transmitted infection (STI) clinics, and finger-stick whole-blood testing is the only rapid HIV test being used.

The "findings underscore the importance of confirming all reactive HIV tests, both from oral fluid and whole-blood specimens,” according to MMWR. They further indicate that the health department's "strategy of following-up reactive oral fluid test results with an immediate finger-stick whole-blood test reduced the number of apparent false-positive oral fluid test results and might be a useful strategy in other settings and locations.” The report also noted that, "The U.S. Center of Disease Control and Prevention [CDC; Atlanta, GA, USA] continues to encourage the use of rapid HIV tests because they increase the number of persons who are tested and who receive their test results.”

This report was provided by the Kaiser Daily Health Policy Report
(Menlo Park, CA, USA), a non-profit, private operating foundation focusing on major healthcare issues.


Related Links:
New York City Department of Health and Mental Hygiene
U.S. Center of Disease Control and Prevention
Kaiser Daily Health Policy Report

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.